Direxion Daily S&P Biotech Bull 3x Shares ETF Newsroom

Stifel Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $295

Moomoo NewsAug 30 18:31 ET

Alnylam Pharmaceuticals Analyst Ratings

BenzingaAug 30 13:41 ET

H.C. Wainwright Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $400

Moomoo NewsAug 30 10:31 ET

United Therapeutics Is Maintained at Outperform by Oppenheimer

Dow JonesAug 28 09:08 ET

United Therapeutics Analyst Ratings

BenzingaAug 28 08:58 ET

Oppenheimer Maintains United Therapeutics(UTHR.US) With Buy Rating, Raises Target Price to $575

Moomoo NewsAug 28 08:32 ET

Truist Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Maintains Target Price $120

Moomoo NewsAug 28 07:32 ET

Jefferies Maintains Exact Sciences(EXAS.US) With Buy Rating, Maintains Target Price $75

Moomoo NewsAug 28 06:34 ET

Exact Sciences Analyst Ratings

BenzingaAug 27 18:12 ET

Truist Financial Maintains Viking Therapeutics(VKTX.US) With Buy Rating, Announces Target Price $120

Moomoo NewsAug 27 14:32 ET

Buy Rating on Viking Therapeutics: A Strategic Opportunity Amid Market Overreaction

TipRanksAug 27 14:13 ET

BMO Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300

Moomoo NewsAug 27 07:34 ET

Alnylam Pharmaceuticals Price Target Raised to $280.00/Share From $248.00 by JP Morgan

Dow JonesAug 26 10:53 ET

RBC Capital Maintains Alnylam Pharmaceuticals(ALNY.US) With Buy Rating, Maintains Target Price $300

Moomoo NewsAug 26 07:31 ET

J.P. Morgan Maintains Alnylam Pharmaceuticals(ALNY.US) With Hold Rating

Moomoo NewsAug 26 07:31 ET

Evercore ISI Raises Price Target on AbbVie to $192 From $180, Keeps Outperform Rating

MT NewswiresAug 26 07:16 ET

Regeneron Pharmaceuticals Analyst Ratings

BenzingaAug 23 10:27 ET

AbbVie Analyst Ratings

BenzingaAug 23 10:26 ET

Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344

Moomoo NewsAug 23 07:31 ET

Piper Sandler Maintains Regeneron Pharmaceuticals(REGN.US) With Buy Rating, Raises Target Price to $1,242

Moomoo NewsAug 23 07:31 ET